EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Successful dose reduction of dupilumab in atopic dermatitis

Michael R Ardern-Jones iD, Emily E Buchanan, Samba Njungu, Daniel O'Driscoll

British Journal of Dermatology · 2023

DOI: 10.1093/bjd/ljad011 ↗

Kurz gefasst

Fachartikel in der Zeitschrift British Journal of Dermatology, 2023. Verfasst von Michael R Ardern-Jones und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, University Hospital Southampton NHS Foundation Trust. Hauptthemen laut MEDLINE: Dermatitis, Atopic. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 8 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Current UK, European and USA atopic dermatitis guidelines do not currently advise on the possibility of dose reduction of dupilumab therapy below the licensed dose of 300 mg subcutaneously every 2 weeks for adults. Here, we report preliminary findings to suggest that in those who respond well to the licensed dose, dupilumab dosing can be reduced while maintaining good disease control. We propose a randomized controlled clinical trial to further analyse the cost effectiveness of this approach.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Dermatitis, AtopicHumansDrug TaperingAntibodies, Monoclonal, HumanizedAntibodies, MonoclonalTreatment OutcomeSeverity of Illness Index

Substanzen

dupilumabAntibodies, Monoclonal, HumanizedAntibodies, Monoclonal

Autor:innen und Institutionen

  • Department of Dermatology, University Hospital Southampton NHS Foundation Trust.
  • Clinical Experimental Sciences, Faculty of Medicine, University of Southampton, Southampton, Hampshire SO16 1DU, UK.

ORCID-Profile: Michael R Ardern-Jones

Zitieren

APA

Ardern-Jones, M. R., Buchanan, E. E., Njungu, S., & O'Driscoll, D. (2023). Successful dose reduction of dupilumab in atopic dermatitis. British Journal of Dermatology. https://doi.org/10.1093/bjd/ljad011

Vancouver

Ardern-Jones MR, Buchanan EE, Njungu S, O'Driscoll D. Successful dose reduction of dupilumab in atopic dermatitis. British Journal of Dermatology. 2023. doi:10.1093/bjd/ljad011

BibTeX
@article{ArdernJones2023,
  author = {Ardern-Jones, Michael R and Buchanan, Emily E and Njungu, Samba and O'Driscoll, Daniel},
  title = {Successful dose reduction of dupilumab in atopic dermatitis},
  journal = {British Journal of Dermatology},
  year = {2023},
  doi = {10.1093/bjd/ljad011}
}
Kostenlos starten →